Standard
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group. / Vickers, Chris J.; Olsen, Christian Adam; Leman, Luke J.; Ghadiri, M. Reza.
In:
ACS Medicinal Chemistry Letters, Vol. 3, No. 6, 06.2012, p. 505-508.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Vickers, CJ
, Olsen, CA, Leman, LJ & Ghadiri, MR 2012, '
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group',
ACS Medicinal Chemistry Letters, vol. 3, no. 6, pp. 505-508.
https://doi.org/10.1021/ml300081uAPA
Vickers, C. J.
, Olsen, C. A., Leman, L. J., & Ghadiri, M. R. (2012).
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group.
ACS Medicinal Chemistry Letters,
3(6), 505-508.
https://doi.org/10.1021/ml300081uVancouver
Vickers CJ
, Olsen CA, Leman LJ, Ghadiri MR.
Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group.
ACS Medicinal Chemistry Letters. 2012 Jun;3(6):505-508.
https://doi.org/10.1021/ml300081uAuthor
Vickers, Chris J. ; Olsen, Christian Adam ; Leman, Luke J. ; Ghadiri, M. Reza. / Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group. In: ACS Medicinal Chemistry Letters. 2012 ; Vol. 3, No. 6. pp. 505-508.
Bibtex
@article{3a1389483e31467e923184f9ed57c57c,
title = "Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group",
keywords = "HDAC inhibitors, zinc binding group, cancer therapy, tetrapeptide, apicidin",
author = "Vickers, {Chris J.} and Olsen, {Christian Adam} and Leman, {Luke J.} and Ghadiri, {M. Reza}",
year = "2012",
month = jun,
doi = "10.1021/ml300081u",
language = "English",
volume = "3",
pages = "505--508",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "6",
}
RIS
TY - JOUR
T1 - Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group
AU - Vickers, Chris J.
AU - Olsen, Christian Adam
AU - Leman, Luke J.
AU - Ghadiri, M. Reza
PY - 2012/6
Y1 - 2012/6
KW - HDAC inhibitors
KW - zinc binding group
KW - cancer therapy
KW - tetrapeptide
KW - apicidin
U2 - 10.1021/ml300081u
DO - 10.1021/ml300081u
M3 - Journal article
C2 - 24900500
VL - 3
SP - 505
EP - 508
JO - ACS Medicinal Chemistry Letters
JF - ACS Medicinal Chemistry Letters
SN - 1948-5875
IS - 6
ER -
